Fluorescent proteins in animal cells for process development: Optimization of sodium butyrate treatment as an example
Open accessThe DOI matches its Crossref record.
Abstract
Fluorescent proteins expressed in mammalian cells can be quantified quickly and noninvasively with a standard fluorescence plate reader. We have previously exploited this quality in cell growth assessment (Hunt et al., 1999b). In this work, different CHO cell lines constitutively expressing fluorescent proteins were evaluated as model systems for process development and optimization. Our results demonstrate that the fluorescence of these cell lines quickly reveals conditions that might improve the overall productivity. Sodium butyrate, a well‐known yet unpredictable enhancer of production, was chosen for this study. Due to the competing effects of sodium butyrate (“butyrate”) on expression and cell number, the maximal overall productivity represents a compromise between enhancement of production and toxicity. Based on fluorescence only, it is possible to separate effects on cell number and specific production by combining microplate fluorescence measurements with data obtained by flow cytometry. This allows for rapid screening of different clones without counting cells or quantifying the recombinant protein, a highly attractive feature if the expression of green fluorescent protein (GFP) was correlated to that of a protein of interest. For all clones tested, negative effects of butyrate on proliferation were similar, while net enhancement of expression was characteristic for each clone. Therefore, it is necessary to optimize treatment for each individual clone. This work demonstrates that, based on the fluorescence of GFP‐expresssing cell lines, it is possible to examine noninvasively three critical, generic parameters of butyrate treatment: butyrate concentration, exposure time, and culture phase at the time of addition. © 2002 John Wiley & Sons, Inc. Biotechnol Bioeng 77: 528–537, 2002; DOI 10.1002/bit.10108
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Enhanced Production of Monomeric Interferon-β by CHO Cells through the Control of Culture Conditions
Rodriguez, J., Spearman, M., Huzel, N., & Butler, M. (2008) · Biotechnology Progress · doi:10.1021/bp049807b · Cited by 145
Sunley, K., & Butler, M. (2010) · Biotechnology Advances · doi:10.1016/j.biotechadv.2010.02.003 · Cited by 136
“Sodium butyrate (NaBu) (Hendrick et al., 2001, Hunt et al., 2002, Hwa Chang et al., 2002), pentanoic acid (Kumar et al., 2007) and dimethyl sulfoxide (Hwa Chang et al., 2002; Liu et al., 2001) (DMSO) are compoundswhich have been used successfully in existing bioprocesses, modulating CDK and CKI…”
BackgroundMethodSung, Y. H., Song, Y. J., Lim, S. W., Chung, J. Y., & Lee, G. M. (2004) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2004.05.003 · Cited by 92
Park, J. H., Noh, S. M., Woo, J. R., Kim, J. W., & Lee, G. M. (2016) · Biotechnology Journal · doi:10.1002/biot.201500327 · Cited by 81
Ha, T. K., Kim, D., Kim, C. L., Grav, L. M., & Lee, G. M. (2022) · Biotechnology Advances · doi:10.1016/j.biotechadv.2021.107831 · Cited by 74
Metadata
- Authors
- Hunt, L., Batard, P., Jordan, M., & Wurm, F. M.
- Venue
- Biotechnology and Bioengineering
- Publisher
- Wiley
- Published
- 2002-01-10
- Volume
- 77
- Issue
- 5
- Pages
- 528-537
- ISSN
- 0006-3592 (ISSN-L)
- 1097-0290
- OpenAlex
- W2098291790
- Cited by
- 56
- References
- 0
- FWCI
- 1.94
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fluorescent proteins in animal cells for process development: Optimization of sodium butyrate treatment as an example. https://app.cochat.ai/papers/10.1002/bit.10108
- The paper
- Hunt, L., Batard, P., Jordan, M., & Wurm, F. M. (2002). Fluorescent proteins in animal cells for process development: Optimization of sodium butyrate treatment as an example. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.10108
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.